Advising Mason Capital Management in leading an equity consortium on the acquisition of CBandI Storage Solutions from McDermott International.
Advising TSD Mobility Solutions on its sale to The Reynolds and Reynolds Company.
Advising AlTi Global on a US$450m strategic investment from Allianz X and Constellation Wealth Capital.
Advising Two Harbors Investment Corp. on the acquisition by Matrix Financial Services Corporation of RoundPoint Mortgage Servicing LLC.
Advising AngioDynamics on the US$100m sale of its Dialysis portfolio and BioSentry product to Merit Medical Systems.
Advising MBIA Inc. and a joint venture with Bardin Hill Investment Partners on the Section 363 acquisition of MD Helicopters.
Advising one, a SPAC, on its US$2.1bn business combination with MarkForged, Inc.
Advising Portico Capital Advisors on its sale to Cowen Inc.
Advising Superior Integrated Solutions/Darwin Automotive on its sale to J.D. Power.
Advising Monocle Acquisition Corporation on its merger with AerSale Corp.
Advising AngioDynamics on its sale of its NAMIC® fluid management portfolio to Medline Industries, its acquisitions of RadiaDyne and the BioSentry Tract Sealant assets of Surgical Specialties and several other transactions.
Advising Inteva Products on the sale of its roof systems business to CIE Automotive.
Advising ACRES Capital on the acquisition of the external manager of public REIT Exantas Capital Corp.
Advising Corindus Vascular Robotics on its US$1.1bn acquisition by Siemens Healthineers.
Advising Elliott Management Corporation on its majority equity investment in Channel Partners Capital.
Advising New Mexico Health Connections on the sale of its commercial health insurance business to Evolent Health.
Advising BOLD on its acquisition of substantially all assets associated with the Resume Companion business.
Advising Community Bank System on its acquisition of Steuben Trust Corporation and its acquisition of Kinderhook Bank Corp.
Advising Sompo International on its acquisition of the operating subsidiaries of Lexon Surety Group, the second largest independent surety insurer in the U.S.
Advising The Medicines Company on its agreement to sell its infectious disease business to Melinta Therapeutics for US$270m plus royalty payments.